NSE filing, NSE: AUROPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Aurobindo Pharma Ltd: key numbers
- Share price
- ₹1,799.00
- Market cap
- ₹1,04,486 Cr
- Revenue (annual)
- ₹33,653 Cr
- Net profit (annual)
- ₹3,505 Cr
- P/E (TTM)
- 24.8×Sector 49.0×
- Promoter holding
- 51.88%+0.00% QoQ
- FII holding
- 17.41%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aurobindo Pharma Ltd
All →Aurobindo Pharma Annual General Meeting
Aurobindo Pharma seeks postal ballot approval for an independent director's reappointment, two executive remuneration revisions and a revised independent director commission. E-voting closes December 22, 2026.
Aurobindo Pharma Business Update
Aurobindo Pharma disclosed that US FDA classified its Lannett facility inspection as Official Action Indicated (OAI). The company states there is no quantifiable financial or operational impact.
Aurobindo Pharma Acquisition Worth ₹29 Cr
Aurobindo's subsidiary Auropharm Overseas will buy 100% of Auro Pharma LLC, a Russian step-down subsidiary, for about Rs 29 crore cash. It is an internal group reorganisation.
- Value
- ₹29.00 Cr
- Execution
- 60-90 days
Aurobindo Pharma Management Change
Aurobindo Pharma's board approved reappointing independent director Mangalam Ramasubramanian Kumar for a second five-year term from April 1, 2027. Shareholder approval by postal ballot is required.
- Execution
- Five years from April 1, 2027
Aurobindo Pharma Merger & Restructuring Worth ₹29 Cr
Aurobindo Pharma approved transferring 100% of Auro Pharma LLC, Russia, between wholly owned subsidiaries. Cash consideration is about INR 29 crore, subject to adjustments.
- Value
- ₹29.00 Cr
- Execution
- 60-90 days
Aurobindo Pharma Acquisition
Aurobindo Pharma announced a board-approved proposal to merge two wholly owned subsidiaries, Auroactive Pharma into Apitoria Pharma, via NCLT scheme. No cash consideration; the share-exchange ratio issues 23,95,900 shares of Apitoria.
Other business update announcements
All →Ritco Logistics Business Update
Ritco Logistics reported new transportation contract wins from ISRPL, Saint-Gobain and others in October 2026. The update also covers TrucksUp's monthly FASTag, financing, fuel and subscription metrics.
Permanent Magnets Business Update
Permanent Magnets' wholly owned subsidiary Quantum Magnetics will inaugurate its NdFeB permanent magnet plant in Vasai on 8 December 2026. The facility will serve EV, renewable energy and electronics applications.
Cohance Lifesciences Business Update
Cohance Lifesciences disclosed that USFDA issued the Establishment Inspection Report for its Shamshabad formulation facility, classifying the inspection as Voluntary Action Indicated (VAI). The inspection is now concluded.
Freshara Agro Exports Business Update
Freshara Agro Exports received ASSOCHAM's 'Best Manufacturing - Export of the Year 2026' award on November 20, 2026. The award recognises growth in its export business.
Sat Kartar Life Business Update
Sat Kartar Life received the Ayush Quality Mark Certification for its Sanjeevan unit. The certification recognises its quality standards and operational practices.
Dev Accelerator Business Update
Dev Accelerator filed its October 2026 newsletter, recapping Q2 FY27 results and PALFINGER's Pune office inauguration. The revenue and EBITDA figures restate results already reported.